MHM's David Diamond Discusses How Biotechs Can Avoid Common Pitfalls of Going Public in Life Science Leader

David Diamond, MHM Shareholder and Chair of Kreston International's Global Technology Special Interest Group, has been featured in the May issue of Life Science Leader magazine.

David's piece, titled "How Biotechs Can Avoid The Common Pitfalls Of Going Public" discusses issues that technology and life science companies face when contemplating an IPO.

Published on May 04, 2018